<DOC>
	<DOC>NCT02641587</DOC>
	<brief_summary>The overall goal of the study is to demonstrate reduction in the levels of biomarkers of exposure (BoExp) to selected harmful and potentially harmful constituents (HPHCs) and to obtain safety information in healthy subjects using the Carbon Heated Tobacco Product 1.2 (CHTP 1.2) as compared to smokers continuing smoking combustible cigarettes (CC) in a confinement setting for 5 days (exclusive use) followed by an ambulatory setting of 85 days.</brief_summary>
	<brief_title>Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.</brief_title>
	<detailed_description />
	<criteria>Subject is aged â‰¥ 28 years. Subject is Caucasian. Subject is healthy, as judged by the Investigator. Subject has smoked at least 10 commercially available nonmenthol CCs per day (no brand restrictions) at least for the last 6 weeks prior to the screening visit and admission. Subject has smoked at least for the last 10 years. Subject does not plan to quit smoking in the next 6 months. As per Investigator judgment, the subject cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason). Subject has received medication within 14 days or within 5 halflives of the medication (whichever is longer), which has an impact on cytochrome P450 1A2 (CYP1A2) or cytochrome P450 2A6 (CYP2A6) activity. Female subject is pregnant or breast feeding. Female subject does not agree to use an acceptable method of effective contraception.</criteria>
	<gender>All</gender>
	<minimum_age>28 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Smoking</keyword>
	<keyword>Combustible cigarette</keyword>
	<keyword>Reduced exposure</keyword>
	<keyword>Confinement</keyword>
	<keyword>Ambulatory</keyword>
	<keyword>Carbon Heated Tobacco Product</keyword>
</DOC>